Woisetschläger, Max <br/><br/>
In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her-2/neu binding sites.  [electronic resource] 

 -  Biotechnology journal  Jun 2014 
 - 844-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1860-7314 
<br/><br/><label>Standard No.: </label>10.1002/biot.201300387  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--chemistry<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--chemistry<br/>Binding Sites<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>HEK293 Cells<br/>Humans<br/>Immunoglobulin Fc Fragments--chemistry<br/>In Vitro Techniques<br/>Mice<br/>Neoplasm Transplantation<br/>Receptor, ErbB-2--chemistry<br/>Trastuzumab